AAAAAA

   
Results: 1-25 |
Results: 25
CLINICAL-EVALUATION OF 2 DOSAGES AND SCHEDULES OF IFOSFAMIDE IN COMBINATION WITH CISPLATIN IN NEOADJUVANT CHEMOTHERAPY OF PATIENTS WITH ADVANCED (STAGE III-IV) HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PHASE-II RANDOMIZED STUDY
Authors: MANTOVANI G GHIANI M LAI P MACCIO A DESSI D SUCCU G MASSA D CURRELI L MULAS C ESU S PROTO E CADEDDU G TORE G
Citation: G. Mantovani et al., CLINICAL-EVALUATION OF 2 DOSAGES AND SCHEDULES OF IFOSFAMIDE IN COMBINATION WITH CISPLATIN IN NEOADJUVANT CHEMOTHERAPY OF PATIENTS WITH ADVANCED (STAGE III-IV) HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PHASE-II RANDOMIZED STUDY, Oncology Reports, 5(6), 1998, pp. 1499-1505
MEDROXYPROGESTERONE ACETATE AND MEGESTROL-ACETATE REDUCE CISPLATIN-INDUCED SEROTONIN RELEASE FROM HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF CANCER-PATIENTS
Authors: MANTOVANI G MACCIO A LAI P ESU S MASSA E SANTONA MC MASSA D DESSI D GHIANI M
Citation: G. Mantovani et al., MEDROXYPROGESTERONE ACETATE AND MEGESTROL-ACETATE REDUCE CISPLATIN-INDUCED SEROTONIN RELEASE FROM HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF CANCER-PATIENTS, Oncology Reports, 5(1), 1998, pp. 121-124
COMPARISON OF ORAL 5-HT3-RECEPTOR ANTAGONISTS AND LOW-DOSE ORAL METOCLOPRAMIDE PLUS IM DEXAMETHASONE FOR THE PREVENTION OF DELAYED EMESIS IN HEAD AND NECK-CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN
Authors: MANTOVANI G MACCIO A CURRELI L LAMPIS B GHIANI M BIANCHI A CONTU P
Citation: G. Mantovani et al., COMPARISON OF ORAL 5-HT3-RECEPTOR ANTAGONISTS AND LOW-DOSE ORAL METOCLOPRAMIDE PLUS IM DEXAMETHASONE FOR THE PREVENTION OF DELAYED EMESIS IN HEAD AND NECK-CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Oncology Reports, 5(1), 1998, pp. 273-280
ABDOMINAL AND PELVIC STOP-FLOW (HYPOXIC, CHEMOTHERAPEUTIC LOCO-REGIONAL TREATMENT) - PRELIMINARY-REPORT OF A PHASE-I EARLY PHASE-II STUDY
Authors: FACCHINI G MASSIDA B TORTORIELLO A SANTANGELO M CROVELLA F CARBONE I ROMANO G RENDA A DISALVO E NOVI A DODARO C CAMAGGI CM STROCCHI E IONTA MT IACCARINO V MALLARINI G GHIANI M BIANCHI A MARZANO N MEMEO V MEMOLI B MORELLI GC MANTOVANI G IAFFAIOLI RV
Citation: G. Facchini et al., ABDOMINAL AND PELVIC STOP-FLOW (HYPOXIC, CHEMOTHERAPEUTIC LOCO-REGIONAL TREATMENT) - PRELIMINARY-REPORT OF A PHASE-I EARLY PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 190-190
INTERIM RESULTS OF A DOSE-INTENSE PHASE-I COMBINATION CHEMOTHERAPY REGIMEN WITH CISPLATIN AND EPIRUBICIN INCLUDING MEDROXYPROGESTERONE ACETATE (MPA) AND RIL-2 IN PRIMARY LUNG-CANCER
Authors: MANTOVANI G MACCIO A LAI P MASSA E GHIANI M SANTONA MC MUDU C CURRELI L MANCA G VERSACE R PISANO M
Citation: G. Mantovani et al., INTERIM RESULTS OF A DOSE-INTENSE PHASE-I COMBINATION CHEMOTHERAPY REGIMEN WITH CISPLATIN AND EPIRUBICIN INCLUDING MEDROXYPROGESTERONE ACETATE (MPA) AND RIL-2 IN PRIMARY LUNG-CANCER, Annals of oncology, 9, 1998, pp. 492-492
PREVENTION OF ACUTE EMESIS IN CANCER-PATIENTS RECEIVING HIGH-DOSE CISPLATIN (HD-CDDP) - COMPARISON OF TRANSDERMAL FENTANYL (TTS-F) VS IV ONDANSETRON (OND), BOTH COMBINED WITH DEXAMETHASONE (D)
Authors: CURRELI L GHIANI M DESSI D MASSA D MULAS C SUCCU G MANTOVANI G
Citation: L. Curreli et al., PREVENTION OF ACUTE EMESIS IN CANCER-PATIENTS RECEIVING HIGH-DOSE CISPLATIN (HD-CDDP) - COMPARISON OF TRANSDERMAL FENTANYL (TTS-F) VS IV ONDANSETRON (OND), BOTH COMBINED WITH DEXAMETHASONE (D), Annals of oncology, 9, 1998, pp. 712-712
ANTIEMETIC EFFECT OF FENTANYL IN CISPLATIN-INDUCED ACUTE EMESIS (NAUSEA VOMITING)/
Authors: MANTOVANI G CURRELI L GHIANI M MACCIO A
Citation: G. Mantovani et al., ANTIEMETIC EFFECT OF FENTANYL IN CISPLATIN-INDUCED ACUTE EMESIS (NAUSEA VOMITING)/, Annals of oncology, 9, 1998, pp. 214-214
NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2
Authors: MANTOVANI G GEBBIA V AIROLDI M BUMMA C CONTU P BIANCHI A GHIANI M DESSI D MASSA E CURRELI L LAMPIS B LAI P MULAS C TESTA A PROTO E CADEDDU G TORE G
Citation: G. Mantovani et al., NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 47(3), 1998, pp. 149-156
CYTOKINE ACTIVITY IN CANCER-RELATED ANOREXIA CACHEXIA - ROLE OF MEGESTROL-ACETATE AND MEDROXYPROGESTERONE ACETATE/
Authors: MANTOVANI G MACCIO A LAI P MASSA E GHIANI M SANTONA MC
Citation: G. Mantovani et al., CYTOKINE ACTIVITY IN CANCER-RELATED ANOREXIA CACHEXIA - ROLE OF MEGESTROL-ACETATE AND MEDROXYPROGESTERONE ACETATE/, Seminars in oncology, 25(2), 1998, pp. 45-52
TUMOR-ASSOCIATED LYMPHOMONOCYTES (TALM) FROM NEOPLASTIC EFFUSIONS SECONDARY TO OVARIAN-CANCER ARE IMMUNOLOGICALLY DEFECTIVE BUT ARE ABLE TORELEASE CYTOKINES
Authors: MANTOVANI G MACCIO A LAI P ESU S GHIANI M DESSI D MASSA E MELIS GB DELGIACCO GS
Citation: G. Mantovani et al., TUMOR-ASSOCIATED LYMPHOMONOCYTES (TALM) FROM NEOPLASTIC EFFUSIONS SECONDARY TO OVARIAN-CANCER ARE IMMUNOLOGICALLY DEFECTIVE BUT ARE ABLE TORELEASE CYTOKINES, Oncology Reports, 4, 1997, pp. 247-251
CLINICAL AND IMMUNOLOGICAL EVALUATION OF SCHIZOPHYLLAN (SPG) IN COMBINATION WITH STANDARD CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: MANTOVANI G BIANCHI A CURRELI L GHIANI M ASTARA G LAMPIS B SANTONA MC DESSI D ESU S LAI P MASSA E MACCIO A PROTO E
Citation: G. Mantovani et al., CLINICAL AND IMMUNOLOGICAL EVALUATION OF SCHIZOPHYLLAN (SPG) IN COMBINATION WITH STANDARD CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, International journal of oncology, 10(1), 1997, pp. 213-221
CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS S.C. RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC -PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT
Authors: MANTOVANI G MACCIO A LAI P ESU S MASSA E GHIANI M ASTARA G MANCA G MASSA D LAMPIS B SUCCU G PISANO M VERSACE R PUSCEDDU G
Citation: G. Mantovani et al., CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS S.C. RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC -PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT, European journal of cancer, 33, 1997, pp. 1080-1080
ABDOMINAL AND PELVIC STOP-FLOW (HYPOXIC, CHEMOTHERAPEUTIC LOCO-REGIONAL TREATMENT) - PRELIMINARY-REPORT OF A PHASE-I STUDY
Authors: IAFFAIOLI RV MASSIDDA B FACCHINI G TORTORIELLO A SANTANGELO M CROVELLA F CARBONE I RENDA A ROMANO G DODARO C DISALVO E MEMOLI B IACCARINO V MALLARINI G BIANCHI A GHIANI M CAMAGGI CM STROCCHI E IONTA MT GUADAGNI S MANTOVANI G
Citation: Rv. Iaffaioli et al., ABDOMINAL AND PELVIC STOP-FLOW (HYPOXIC, CHEMOTHERAPEUTIC LOCO-REGIONAL TREATMENT) - PRELIMINARY-REPORT OF A PHASE-I STUDY, European journal of cancer, 33, 1997, pp. 1142-1142
NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC) - A MULTICENTER PHASE-III RANDOMIZED STUDY COMPARING CISPLATIN (CDDP)-FU WITH CDDP+5-FU PLUS RECOMBINANT INTERLEUKIN-2 (RIL 2) - PRELIMINARY-RESULTS(5)
Authors: MANTOVANI G AIROLDI M BIANCHI A GHIANI M SUCCU G MASSA D CURRELI L LAMPIS B LAI P CADEDDU G BUMMA C
Citation: G. Mantovani et al., NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC) - A MULTICENTER PHASE-III RANDOMIZED STUDY COMPARING CISPLATIN (CDDP)-FU WITH CDDP+5-FU PLUS RECOMBINANT INTERLEUKIN-2 (RIL 2) - PRELIMINARY-RESULTS(5), European journal of cancer, 33, 1997, pp. 57-57
CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS SC RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC - PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT
Authors: MANTOVANI G MACCIO A LAI P ESU S MASSA E GHIANI M ASTARA G MANCA G MASSA D LAMPIS B SUCCU G PISANO M VERSACE R PUSCEDDU G
Citation: G. Mantovani et al., CHEMOIMMUNOTHERAPY WITH WEEKLY CISPLATIN AND ETOPOSIDE PLUS SC RIL-2 PLUS ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN STAGE IIIB-IV NSCLC - PRELIMINARY-RESULTS ON CLINICAL-RESPONSE AND ON IMMUNOLOGICAL ASSESSMENT, European journal of cancer, 33, 1997, pp. 58-58
TUMOR-ASSOCIATED LYMPHO-MONOCYTES FROM NEOPLASTIC EFFUSIONS ARE IMMUNOLOGICALLY DEFECTIVE IN COMPARISON WITH PATIENT AUTOLOGOUS PBMCS BUT ARE CAPABLE OF RELEASING HIGH AMOUNTS OF VARIOUS CYTOKINES
Authors: MANTOVANI G MACCIO A PISANO M VERSACE R LAI P ESU S MASSA E GHIANI M DESSI D MELIS GB DELGIACCO GS
Citation: G. Mantovani et al., TUMOR-ASSOCIATED LYMPHO-MONOCYTES FROM NEOPLASTIC EFFUSIONS ARE IMMUNOLOGICALLY DEFECTIVE IN COMPARISON WITH PATIENT AUTOLOGOUS PBMCS BUT ARE CAPABLE OF RELEASING HIGH AMOUNTS OF VARIOUS CYTOKINES, International journal of cancer, 71(5), 1997, pp. 724-731
NEOADJUVANT (PRIMARY) ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENTOF LOCALLY ADVANCED LARYNGEAL CARCINOMA - LARYNX PRESERVATION AND CLINICAL-RESPONSE
Authors: MANTOVANI G GEBBIA V PROTO E COSSU F BIANCHI A CURRELI L GHIANI M MASSA E ASTARA G LAMPIS B DESSI D SANTONA MC
Citation: G. Mantovani et al., NEOADJUVANT (PRIMARY) ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENTOF LOCALLY ADVANCED LARYNGEAL CARCINOMA - LARYNX PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(5), 1996, pp. 1035-1043
NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED ORAL CAVITY AND OROPHARYNX CANCER - A TENTATIVE QUANTITATIVE-EVALUATION OF ORGAN PRESERVATION AND CLINICAL-RESPONSE
Authors: MANTOVANI G GEBBIA V PROTO E COSSU F BIANCHI A CURRELI L GHIANI M ASTARA G LAMPIS B DESSI D SANTONA MC MASSA E
Citation: G. Mantovani et al., NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED ORAL CAVITY AND OROPHARYNX CANCER - A TENTATIVE QUANTITATIVE-EVALUATION OF ORGAN PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(3), 1996, pp. 571-578
COMPARISON OF GRANISETRON, ONDANSETRON, AND TROPISETRON IN THE PROPHYLAXIS OF ACUTE NAUSEA AND VOMITING INDUCED BY CISPLATIN FOR THE TREATMENT OF HEAD AND NECK-CANCER - A RANDOMIZED CONTROLLED TRIAL
Authors: MANTOVANI G MACCIO A BIANCHI A CURRELI L GHIANI M PROTO E SANTONA MC
Citation: G. Mantovani et al., COMPARISON OF GRANISETRON, ONDANSETRON, AND TROPISETRON IN THE PROPHYLAXIS OF ACUTE NAUSEA AND VOMITING INDUCED BY CISPLATIN FOR THE TREATMENT OF HEAD AND NECK-CANCER - A RANDOMIZED CONTROLLED TRIAL, Cancer, 77(5), 1996, pp. 941-948
COMPARISON OF GRANISETRON VS ONDANSETRON VS TROPISETRON IN THE PROPHYLAXIS OF ACUTE NAUSEA AND VOMITING INDUCED BY HIGHLY EMETOGENIC CHEMOTHERAPY (HIGH-DOSE CISPLATIN) FOR TREATMENT OF PRIMARY HEAD AND NECK-CANCER - AN OPEN CROSS-OVER RANDOMIZED CONTROLLED TRIAL (RCT)
Authors: MANTOVANI G MACCIO A BIANCHI A CURRELI L GHIANI M SANTONA MC TESTA A GEBBIA V
Citation: G. Mantovani et al., COMPARISON OF GRANISETRON VS ONDANSETRON VS TROPISETRON IN THE PROPHYLAXIS OF ACUTE NAUSEA AND VOMITING INDUCED BY HIGHLY EMETOGENIC CHEMOTHERAPY (HIGH-DOSE CISPLATIN) FOR TREATMENT OF PRIMARY HEAD AND NECK-CANCER - AN OPEN CROSS-OVER RANDOMIZED CONTROLLED TRIAL (RCT), European journal of cancer, 31A, 1995, pp. 1206-1206
TUMOR-ASSOCIATED LYMPHOCYTES (TAL) ARE COMPETENT TO PRODUCE HIGHER LEVELS OF CYTOKINES IN NEOPLASTIC PLEURAL AND PERITONEAL EFFUSIONS THAN THOSE FOUND IN SERA AND ARE ABLE TO RELEASE INTO CULTURE HIGHER LEVELSOF IL-2 AND IL-6 THAN THOSE RELEASED BY PBMC
Authors: MANTOVANI G MACCIO A VERSACE R PISANO M LAI P ESU S GHIANI M DESSI D TURNU E SANTONA MC CHERCHI R DELGIACCO GS
Citation: G. Mantovani et al., TUMOR-ASSOCIATED LYMPHOCYTES (TAL) ARE COMPETENT TO PRODUCE HIGHER LEVELS OF CYTOKINES IN NEOPLASTIC PLEURAL AND PERITONEAL EFFUSIONS THAN THOSE FOUND IN SERA AND ARE ABLE TO RELEASE INTO CULTURE HIGHER LEVELSOF IL-2 AND IL-6 THAN THOSE RELEASED BY PBMC, Journal of molecular medicine, 73(8), 1995, pp. 409-416
MEGESTROL-ACETATE IN NEOPLASTIC ANOREXIA CACHEXIA - CLINICAL-EVALUATION AND COMPARISON WITH CYTOKINE LEVELS IN PATIENTS WITH HEAD AND NECK-CARCINOMA TREATED WITH NEOADJUVANT CHEMOTHERAPY
Authors: MANTOVANI G MACCIO A BIANCHI A CURRELI L GHIANI M SANTONA MC DELGIACCO GS
Citation: G. Mantovani et al., MEGESTROL-ACETATE IN NEOPLASTIC ANOREXIA CACHEXIA - CLINICAL-EVALUATION AND COMPARISON WITH CYTOKINE LEVELS IN PATIENTS WITH HEAD AND NECK-CARCINOMA TREATED WITH NEOADJUVANT CHEMOTHERAPY, International journal of clinical & laboratory research, 25(3), 1995, pp. 135-141
NEOADJUVANT CHEMOTHERAPY+ -IMMUNOTHERAPY WITH SC-IL-2 IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PILOT-STUDY/
Authors: MANTOVANI G BIANCHI A CURRELI L GHIANI M
Citation: G. Mantovani et al., NEOADJUVANT CHEMOTHERAPY+ -IMMUNOTHERAPY WITH SC-IL-2 IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PILOT-STUDY/, Biotherapy, 8(2), 1995, pp. 91-98
LACK OF CORRELATION BETWEEN DEFECTIVE CELL-MEDIATED-IMMUNITY AND LEVELS OF SECRETED OR CIRCULATING CYTOKINES IN A STUDY OF 90 CANCER-PATIENTS
Authors: MANTOVANI G MACCIO A ESU S LAI P GHIANI M TURNU E CONTU G VOLPE A DELGIACCO GS
Citation: G. Mantovani et al., LACK OF CORRELATION BETWEEN DEFECTIVE CELL-MEDIATED-IMMUNITY AND LEVELS OF SECRETED OR CIRCULATING CYTOKINES IN A STUDY OF 90 CANCER-PATIENTS, International journal of oncology, 5(6), 1994, pp. 1211-1217
MICROBIAL PURIFICATION TECHNIQUE OF MINERAL DRESSING PLANTS REJECT WATERS
Authors: GHIANI M LOI G PASSARINI N TROIS P ROSSI G
Citation: M. Ghiani et al., MICROBIAL PURIFICATION TECHNIQUE OF MINERAL DRESSING PLANTS REJECT WATERS, FEMS microbiology reviews, 11(1-3), 1993, pp. 153-158
Risultati: 1-25 |